These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23796831)

  • 1. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate.
    Kondo K; Ito N; Niwa T; Danjo K
    Int J Pharm; 2013 Sep; 453(2):523-32. PubMed ID: 23796831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical particle coating using polymethacrylate nanoparticle agglomerates for the preparation of controlled release fine particles: The relationship between coating performance and the characteristics of various polymethacrylates.
    Kondo K; Kato S; Niwa T
    Int J Pharm; 2017 Oct; 532(1):318-327. PubMed ID: 28899765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance.
    Kondo K; Ando C; Niwa T
    Int J Pharm; 2019 Jan; 554():387-398. PubMed ID: 30513400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
    Cerea M; Zheng W; Young CR; McGinity JW
    Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I; Bodmeier R
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying.
    Garekani HA; Moghaddam ZF; Sadeghi F
    Colloids Surf B Biointerfaces; 2013 Aug; 108():374-9. PubMed ID: 23602991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Solventless Pharmaceutical Technique for Manufacture of Pharmaceuticals].
    Kondo K
    Yakugaku Zasshi; 2024; 144(10):919-930. PubMed ID: 39358247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable nanoparticle flocculates for dry powder aerosol formulation.
    Shi L; Plumley CJ; Berkland C
    Langmuir; 2007 Oct; 23(22):10897-901. PubMed ID: 17894513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties.
    Mohylyuk V; Patel K; Scott N; Richardson C; Murnane D; Liu F
    AAPS PharmSciTech; 2019 Nov; 21(1):3. PubMed ID: 31713006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spheronization mechanism of pharmaceutical material crystals processed by extremely high shearing force using a mechanical powder processor.
    Kondo K; Kido K; Niwa T
    Eur J Pharm Biopharm; 2016 Oct; 107():7-15. PubMed ID: 27368746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Controlled-Release Fine Particles Using a Dry Coating Method.
    Nakamura S; Sakamoto T; Ito T; Kabasawa K; Yuasa H
    AAPS PharmSciTech; 2016 Dec; 17(6):1393-1403. PubMed ID: 26769346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of taste-masked swellable drug particles using dry-coating technology with mechanical curing.
    Saeki I; Kondo K; Furukoshi Y; Watanabe Y; Niwa T
    Eur J Pharm Biopharm; 2021 Mar; 160():9-22. PubMed ID: 33472100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the film formation of the dry coating process.
    Kablitz CD; Urbanetz NA
    Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
    Lee YH; Mei F; Bai MY; Zhao S; Chen DR
    J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs.
    Fiegel J; Fu J; Hanes J
    J Control Release; 2004 May; 96(3):411-23. PubMed ID: 15120898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
    Kaialy W; Nokhodchi A
    Int J Pharm; 2013 May; 448(1):58-70. PubMed ID: 23500603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.